Landmark Trials in AMD

A summary of the clinical trials that have shaped—and continue to shape—how we treat AMD.

Saghar Bagheri, MD, PHD; Alberto Quarta, MD; Rouzbeh Abbasgholizadeh, MD; Alessandro Feo, MD; Paolo Forte, MD; David Sarraf, MD; Michael S. Ip, MD; and SriniVas R. Sadda, MD, FARVO

Predicting Progression to GA Using Imaging Biomarkers

Several OCT findings can help clinicians better understand a patient’s risk of progression to sight-threatening disease.

Kelly Donovan, MD, PhD, and Eleonora M. Lad, MD, PhD

Choroidal Nevus Growth Into Melanoma in a Young Patient

Know the clinical risk factors for the development of malignancy.

Henry M. Nguyen, BS; Aruba Zafar, MD; Robert J. Medina, BA; and Carol L. Shields, MD

Angiogenesis 2026: Highlights

New data on wet and dry AMD therapies, AI, and more.

Alex Brodin, MA, Senior Editor, and Rebecca Hepp, MA, Editor-in-Chief